Page last updated: 2024-08-24

triazoles and ANS (Autonomic Nervous System) Diseases

triazoles has been researched along with ANS (Autonomic Nervous System) Diseases in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cappuccio, F; Ceriello, A; Genovese, S; Schnell, O; Standl, E; Valensi, P	1
Bacic, D; Belardinelli, L; Bento, AS; Carneiro, JS; Nearing, BD; Rajamani, S; Verrier, RL	1
Chavarri-Guerra, Y; Goss, PE; Liedke, PE; Pritchard, KI; Shepherd, L; Stearns, V; Tu, D	1
Aurilia, C; Barbanti, P; Bonassi, S; Dall'Armi, V; Egeo, G; Fofi, L; Vanacore, N	1

Reviews

1 review(s) available for triazoles and ANS (Autonomic Nervous System) Diseases

Article	Year
Type 1 diabetes and cardiovascular disease. Cardiovascular diabetology, 2013, Oct-28, Volume: 12 Topics: Antihypertensive Agents; Autonomic Nervous System Diseases; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Drug Therapy, Combination; Exenatide; Exercise Therapy; Glucagon-Like Peptide 1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Insulin; Oxidative Stress; Peptides; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms	2013

Article

Year

Type 1 diabetes and cardiovascular disease.

Cardiovascular diabetology, 2013, Oct-28, Volume: 12

Topics: Antihypertensive Agents; Autonomic Nervous System Diseases; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Drug Therapy, Combination; Exenatide; Exercise Therapy; Glucagon-Like Peptide 1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Insulin; Oxidative Stress; Peptides; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms

2013

Trials

2 trial(s) available for triazoles and ANS (Autonomic Nervous System) Diseases

Article	Year
New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole - Analyses from NCIC CTG MA.17. Breast (Edinburgh, Scotland), 2016, Volume: 27 Topics: Aged; Antineoplastic Agents; Autonomic Nervous System Diseases; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Letrozole; Middle Aged; Multivariate Analysis; Musculoskeletal Diseases; Nitriles; Proportional Hazards Models; Tamoxifen; Time Factors; Treatment Outcome; Triazoles; Vasomotor System	2016
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial. The journal of headache and pain, 2012, Volume: 13, Issue:5 Topics: Adult; Autonomic Nervous System Diseases; Chi-Square Distribution; Double-Blind Method; Female; Functional Laterality; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Physical Examination; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines	2012

Article

Year

New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole - Analyses from NCIC CTG MA.17.

Breast (Edinburgh, Scotland), 2016, Volume: 27

Topics: Aged; Antineoplastic Agents; Autonomic Nervous System Diseases; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Letrozole; Middle Aged; Multivariate Analysis; Musculoskeletal Diseases; Nitriles; Proportional Hazards Models; Tamoxifen; Time Factors; Treatment Outcome; Triazoles; Vasomotor System

2016

Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial.

The journal of headache and pain, 2012, Volume: 13, Issue:5

Topics: Adult; Autonomic Nervous System Diseases; Chi-Square Distribution; Double-Blind Method; Female; Functional Laterality; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Physical Examination; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2012

Other Studies

1 other study(ies) available for triazoles and ANS (Autonomic Nervous System) Diseases

Article	Year
The Selective Cardiac Late Sodium Current Inhibitor GS-458967 Suppresses Autonomically Triggered Atrial Fibrillation in an Intact Porcine Model. Journal of cardiovascular electrophysiology, 2015, Volume: 26, Issue:12 Topics: Acetylcholine; Animals; Anti-Arrhythmia Agents; Arterial Pressure; Atrial Fibrillation; Autonomic Nervous System Diseases; Electric Stimulation; Electrocardiography; Epinephrine; Heart Rate; Male; Pyridines; Sodium Channel Blockers; Sus scrofa; Swine; Triazoles	2015

Article

Year

The Selective Cardiac Late Sodium Current Inhibitor GS-458967 Suppresses Autonomically Triggered Atrial Fibrillation in an Intact Porcine Model.

Journal of cardiovascular electrophysiology, 2015, Volume: 26, Issue:12

Topics: Acetylcholine; Animals; Anti-Arrhythmia Agents; Arterial Pressure; Atrial Fibrillation; Autonomic Nervous System Diseases; Electric Stimulation; Electrocardiography; Epinephrine; Heart Rate; Male; Pyridines; Sodium Channel Blockers; Sus scrofa; Swine; Triazoles

2015